A randomised controlled trial of plasma filtration in severe paediatric sepsis

Elliot J Long1, Anna Taylor, Carmel Delzoppo

  • 1Royal Children's Hospital, Melbourne, VIC, Australia. elliot.long@rch.org.au

Insights

Plasma filtration did not significantly improve 28-day survival in children with severe sepsis. This study was underpowered due to poor recruitment, but found no significant difference in mortality between groups.

Area of Science:

  • Pediatric critical care medicine
  • Sepsis research
  • Extracorporeal therapies

Background:

  • Severe sepsis in children is a life-threatening condition.
  • Standard therapy for septic shock has limitations.
  • Plasma filtration is a potential adjunctive treatment.

Purpose of the Study:

  • To evaluate if plasma filtration improves 28-day survival in pediatric severe sepsis.
  • To assess the impact of plasma filtration on organ system failure and mortality.

Main Methods:

  • A multicenter randomized controlled trial involving 48 infants and children with severe sepsis.
  • Patients were assigned to plasma filtration or standard therapy.
  • Primary outcome was 28-day survival; secondary outcomes included organ failure and functional status.

Main Results:

  • The trial was halted early due to insufficient recruitment.
  • Plasma filtration group had higher initial disease severity.
  • No significant difference in 28-day mortality was observed between groups after adjusting for illness severity.

Conclusions:

  • The study was underpowered to determine the efficacy of plasma filtration for severe sepsis in children.
  • Plasma filtration did not demonstrate a significant survival benefit in this trial.
  • Further research with adequate patient numbers is needed.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...